Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 526 across all filing types
Latest filing 2026-02-02 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification to stock exchanges about a scheduled investors and analysts meeting/conference. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document states the meeting will discuss financial and other information already publicly available or covered in a previously submitted Earnings Presentation dated January 18, 2026. There is no actual financial data or report content in this document; it is purely an announcement of an upcoming investor event. The document length is short (1956 characters), and it does not contain financial statements or detailed analysis. Therefore, it is best classified as an Investor Presentation announcement or notice. However, since this document is only an intimation of the scheduled meeting and not the presentation itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about an investor event, not the presentation or report itself.
2026-02-02 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It provides an update on the conclusion of arbitration proceedings related to a subsidiary of the company. The document includes details about the arbitration award and its financial impact but does not contain comprehensive financial statements or detailed financial analysis. It is a regulatory announcement informing the stock exchanges and public about a material event affecting the company. The document length is 4829 characters, which is relatively short and consistent with a regulatory disclosure rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS) as it is a compliance disclosure about a legal/arbitration matter rather than a full Legal Proceedings Report (LTR) or other report types.
2026-01-29 English
Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the completion of a sale transaction of office premises by the company. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document is short (2033 characters) and serves as an announcement of a corporate event (sale of office premises), not a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on January 19, 2026, for the third quarter of fiscal year 2026 (Q3 FY26). It includes opening remarks from company executives, financial highlights, business performance discussion, strategic initiatives, and a Q&A session with analysts. The content is consistent with a full text transcript of a quarterly earnings call, including forward-looking statements, operational updates, and financial metrics. The document references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events including earnings calls. The length of the document (15,000 characters) and the presence of detailed dialogue confirm it is a full transcript rather than a brief announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2026-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying about the availability of the audio recording of an earnings conference call for Q3 FY26. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which governs disclosures related to events like earnings calls. The document does not contain the transcript itself, financial data, or detailed analysis, but rather informs that the audio recording is available on the company's website. The document length is short (1572 characters), and it serves as an announcement rather than the actual earnings release or call transcript. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a formal disclosure related to the earnings call but not the call transcript or earnings release itself.
2026-01-19 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated January 18, 2026, announcing the financial results for the quarter and nine months ended December 31, 2025. It includes detailed financial performance metrics such as revenue, EBITDA, PAT, and EPS for Q3 FY26 and 9M FY26, along with commentary from company executives. The document is titled as a "Q3 & 9M FY26 Press Release" and contains key developments and forward-looking statements. It is not a full quarterly or annual report but an initial announcement of financial results. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. The document length (8663 characters) and content confirm it is not merely an announcement of a report but the actual earnings release text. Q3 2026
2026-01-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.